A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19

Completed · Phase 2 · Has a placebo group

Conditions studied: SARS-CoV-2 Infection

In brief

Clinical trial to compare sublingual low does thimerosal in adults that have symptoms of SARS-CoV-2 Infection against placebo to show a difference in physical characteristics and viral levels.

Key facts

Study ID

NCT04522830

Run by

Beech Tree Labs, Inc.

People needed

28

Starts

2020-07-30

Expected to finish

2021-02-28

Last updated by the study team

2021-04-13

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 40 years of age or older
• Provide written informed consent
• Have a SARS-COV-19 diagnostic test with positive results

You may not qualify if…

• Having an oxygen saturation level below 92% at baseline or currently on Oxygen therapy
• Subjects currently hospitalized
• Subjects who have received a COVID vaccination
• Subjects with a diagnosis of immunodeficiency

Where it is running

• Intermountain Clinical Reserach — Draper, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.